ClinicalTrials.gg
Not yet recruitingNCT07923110Updated Nov 6, 2026

Post-operative Pain and Clinical Outcome After Single-cone Obturation With a Calcium Silicate-based Versus Epoxy Resin Sealer

An interventional study of A calcium silicate-based sealer and An epoxy resin- based sealer in Post Operative Pain, Acute, Irreversible Pulpitis (Toothache) and Pulp Necrosis, Apical Periodontitis, sponsored by University Ghent. Not yet recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by University Ghent · Not applicable, Interventional, and Treatment

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

When the nerve inside a tooth becomes inflamed, it can cause severe pain and may eventually lead to the death of the nerve. In these cases, root canal treatment is necessary to remove the inflamed nerve or to treat or prevent infection associated with a dead nerve.

During root canal treatment, the root canals are carefully cleaned and then filled. This is usually done using a flexible, rubber-like material called gutta-percha, combined with a special dental cement known as a root canal sealer.

Different types of root canal sealers are available, including AH Plus and BioRoot Flow. The aim of this study is to compare these two sealers to determine whether there are differences in pain experienced after treatment and in treatment success, assessed during follow-up visits after 1 and 2 years.

02

Conditions studied

  • Post Operative Pain, Acute
  • Irreversible Pulpitis (Toothache)
  • Pulp Necrosis, Apical Periodontitis
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 138 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

University Ghent is the lead sponsor of 350 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written obtained
  • Age: ≥ 18 years
  • , II \& III
  • Permanent single or multi-rooted mature tooth requiring root-canal treatment
  • Diagnosis: (a)symptomatic irreversible pulpitis or pulp necrosis, with or without apical periodontitis or initially treated

Exclusion criteria

Exclusion Criteria:

  • Unlikely to be able to comply with the study procedures, as judged by the investigator
  • Immature permanent teeth
  • Teeth presenting with aberrant root canal anatomy (e.g., perforation, resorption or canal calcification)
  • Patients presenting with pain in another area and/or tooth of the oral cavity
  • Patient suffering from uncontrolled active periodontitis
  • Patients who took medication that could alter pain perception (e.g. analgesics) within at least 12 h before treatment
  • Known or suspected current
  • History of chemotherapy within 5 years prior to study or radiation in the head and neck region
  • History of other metabolic bone diseases
  • Endodontic retreatment (ortho-and retrograde), reversible pulpitis
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
138 participants (estimated)

Study arms

  • Active comparator
    A calcium silicate-based sealer

    Device: A calcium silicate-based sealer

  • Experimental
    An epoxy resin- based sealer

    Device: An epoxy resin- based sealer

Interventions

  • DeviceA calcium silicate-based sealer

    Root canal obturation is performed using the single-cone technique, in which a gutta-percha cone is inserted into the root canal in combination with a calcium silicate-based sealer: BioRoot Flow

  • DeviceAn epoxy resin- based sealer

    Root canal obturation is performed using the single-cone technique, in which a gutta-percha cone is inserted into the root canal in combination with an epoxy resin-based sealer: AH Plus Jet

06

What researchers measure

Primary outcomes

  1. Post-operative pain

    The post-operative pain is scored with the Visual Analogue Scale (VAS). Patients are asked to fill out a pain diary 6 hours, 24 hours, 48 hours, 72 hours and 7 days after treatment with a pain score on the Visual Analogue Scale. They mark the level of pain on a scale from 0 to 10. Higher scores indicate greater pain intensity.

    Time frame: 6 hours, 24 hours, 48 hours, 72 hours and 7 days after treatment

  2. Treatment outcome

    The 1 and 2 year success rates are determined using a combination of radiographic and clinical outcome measures. * Clinical: The absence of pain, tenderness, swelling and a sinus tract) * Radiographic: The pre-operative and recall periapical radiographs are assessed qualitatively by means of the Periapical Index (PAI) and quantitatively by means of surface area measurements of the APs on periapical radiographs. The two aforementioned outcomes will be combined to determine overall treatment success, which will be classified into three categories: * Strict success criteria (healed): Absence of clinical signs and/or radiographic evidence of complete resolution or the absence of a periapical radiolucency. * Loose success criteria (healing): Absence of clinical signs and a lower PAI-score/ smaller surface of the lesion compared to the pre-operative radiograph. * Failure (non-healing): Presence of clinical signs or unchanged/increased PAI-score (or surface of the lesion) at follow-up.

    Time frame: up to 2 years following treatment

Secondary outcomes

  1. Quality of obturation

    The root canal obturation is evaluated on peri-apical radiograph on the presence of voids. First is stated if a void was present (Yes/No). If so, a distinction is made whether the void was smaller or bigger than 1 mm.

    Time frame: Immediately after treatment

  2. Sealer extrusion

    The presence of sealer extrusion beyond the apical foramen is evaluated as a binary outcome (Yes/No).

    Time frame: Immediately after treatment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07923110
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Nov 2026 (estimated)
Primary completion
Aug 2029 (estimated)
Completion
Aug 2029 (estimated)
Last update
Nov 6, 2026

Study contacts

Prof. Dr. Mieke De bruyne
Contact
Mieke.DeBruyne@uzgent.be
+3293324020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion